# Official Journal C 177/9 Ju

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 177 |
| | |
| English edition | Information and Notices | Volume 479 July 2004 |

ISSN 1725-2423

Official Journal

of the European Union

C 177

English edition

Information and Notices

Volume 479 July 2004

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2004/C 177/1 | Euro exchange rates | 1 |
| 2004/C 177/2 | Prior notification of a concentration (Case No COMP/M.3465 — Syngenta CP / Advanta) (
  1
  ) | 2 |
| 2004/C 177/3 | Prior notification of a concentration (Case No COMP/M.3497 — Pfizer / Campto) — Candidate case for simplified procedure (
  1
  ) | 3 |
| 2004/C 177/4 | Non-opposition to a notified concentration (Case No COMP/M.3414 — APAX/CAPMAN/SOLID) (
  1
  ) | 4 |
| 2004/C 177/5 | Non-opposition to a notified concentration (Case No COMP/M.3411 — UGC / NOOS) (
  1
  ) | 4 |
| 2004/C 177/6 | Non-opposition to a notified concentration (Case No COMP/M.3382 — IBERIA / COBRA INSTALACIONES / SERPISTA JV) (
  1
  ) | 5 |
| 2004/C 177/7 | Non-opposition to a notified concentration (Case No COMP/M.3460 — CHARTERHOUSE / AUTOBAR) (
  1
  ) | 5 |

Notice No

Contents

page

I   Information

Commission

2004/C 177/1

Euro exchange rates

1

2004/C 177/2

Prior notification of a concentration (Case No COMP/M.3465 — Syngenta CP / Advanta) (
  1
  )

1

2

2004/C 177/3

Prior notification of a concentration (Case No COMP/M.3497 — Pfizer / Campto) — Candidate case for simplified procedure (
  1
  )

1

3

2004/C 177/4

Non-opposition to a notified concentration (Case No COMP/M.3414 — APAX/CAPMAN/SOLID) (
  1
  )

1

4

2004/C 177/5

Non-opposition to a notified concentration (Case No COMP/M.3411 — UGC / NOOS) (
  1
  )

1

4

2004/C 177/6

Non-opposition to a notified concentration (Case No COMP/M.3382 — IBERIA / COBRA INSTALACIONES / SERPISTA JV) (
  1
  )

1

5

2004/C 177/7

Non-opposition to a notified concentration (Case No COMP/M.3460 — CHARTERHOUSE / AUTOBAR) (
  1
  )

1

5

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

I Information

Commission

| 9.7.2004 | EN | Official Journal of the European Union | C 177/1 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/1

---

Euro exchange rates (1)

8 July 2004

(2004/C 177/01)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2348 |
| JPY | Japanese yen | 134,58 |
| DKK | Danish krone | 7,4343 |
| GBP | Pound sterling | 0,6668 |
| SEK | Swedish krona | 9,1755 |
| CHF | Swiss franc | 1,5189 |
| ISK | Iceland króna | 88,16 |
| NOK | Norwegian krone | 8,462 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5819 |
| CZK | Czech koruna | 31,457 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 250,87 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6618 |
| MTL | Maltese lira | 0,4263 |
| PLN | Polish zloty | 4,5299 |
| ROL | Romanian leu | 40 912 |
| SIT | Slovenian tolar | 239,88 |
| SKK | Slovak koruna | 39,88 |
| TRL | Turkish lira | 1 787 400 |
| AUD | Australian dollar | 1,7189 |
| CAD | Canadian dollar | 1,6345 |
| HKD | Hong Kong dollar | 9,6306 |
| NZD | New Zealand dollar | 1,8893 |
| SGD | Singapore dollar | 2,1083 |
| KRW | South Korean won | 1 420,64 |
| ZAR | South African rand | 7,5023 |

Currency

Exchange rate

USD

US dollar

1,2348

JPY

Japanese yen

134,58

DKK

Danish krone

7,4343

GBP

Pound sterling

0,6668

SEK

Swedish krona

9,1755

CHF

Swiss franc

1,5189

ISK

Iceland króna

88,16

NOK

Norwegian krone

8,462

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5819

CZK

Czech koruna

31,457

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

250,87

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6618

MTL

Maltese lira

0,4263

PLN

Polish zloty

4,5299

ROL

Romanian leu

40 912

SIT

Slovenian tolar

239,88

SKK

Slovak koruna

39,88

TRL

Turkish lira

1 787 400

AUD

Australian dollar

1,7189

CAD

Canadian dollar

1,6345

HKD

Hong Kong dollar

9,6306

NZD

New Zealand dollar

1,8893

SGD

Singapore dollar

2,1083

KRW

South Korean won

1 420,64

ZAR

South African rand

7,5023

---

(1)

Source: reference exchange rate published by the ECB.

---

| 9.7.2004 | EN | Official Journal of the European Union | C 177/2 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/2

---

Prior notification of a concentration

(Case No COMP/M.3465 — Syngenta CP / Advanta)

(2004/C 177/02)

(Text with EEA relevance)

| 1. | On 2 July 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Syngenta Crop Protection AG (‘Syngenta CP’, Switzerland), belonging to Syngenta International AG (‘Syngenta AG’, Switzerland), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Advanta B.V. (‘Advanta’, Netherlands) by way of purchase of shares. |
| --- | --- |

1.

On 2 July 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Syngenta Crop Protection AG (‘Syngenta CP’, Switzerland), belonging to Syngenta International AG (‘Syngenta AG’, Switzerland), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Advanta B.V. (‘Advanta’, Netherlands) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for undertaking Syngenta CP: agribusiness, in particular crop protection and seeds, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for undertaking Syngenta CP: agribusiness, in particular crop protection and seeds,

| — | for undertaking Syngenta AG: agribusiness, in particular crop protection and seeds, |
| --- | --- |

—

for undertaking Syngenta AG: agribusiness, in particular crop protection and seeds,

| — | for undertaking Advanta: breeding, production and sale of seeds. |
| --- | --- |

—

for undertaking Advanta: breeding, production and sale of seeds.

| 3. | On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax no. +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3465 — Syngenta CP / Advanta, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel. |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax no. +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3465 — Syngenta CP / Advanta, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 9.7.2004 | EN | Official Journal of the European Union | C 177/3 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/3

---

Prior notification of a concentration

(Case No COMP/M.3497 — Pfizer / Campto)

Candidate case for simplified procedure

(2004/C 177/03)

(Text with EEA relevance)

| 1. | On 25 June 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Pfizer Inc. (‘Pfizer’, United-States) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of Aventis Campto Business (‘ACB’ France/Germany), controlled by Sanofi-Aventis S.A. (‘Sanofi-Aventis’, France), by way of purchase of assets. |
| --- | --- |

1.

On 25 June 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Pfizer Inc. (‘Pfizer’, United-States) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of Aventis Campto Business (‘ACB’ France/Germany), controlled by Sanofi-Aventis S.A. (‘Sanofi-Aventis’, France), by way of purchase of assets.

| 2. | The business activities of the undertakings concerned are:






  — | for undertaking Pfizer: a research-based, pharmaceutical company, which discovers, develops, manufactures, and markets prescription medicines for humans and animals, and consumer healthcare products, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for undertaking Pfizer: a research-based, pharmaceutical company, which discovers, develops, manufactures, and markets prescription medicines for humans and animals, and consumer healthcare products,

| — | for undertaking ACB: produces and sells Campto, a treatment for colorectal cancer in Europe, Africa and Asia, under a license from Yakult Honsha Co. Limited, |
| --- | --- |

—

for undertaking ACB: produces and sells Campto, a treatment for colorectal cancer in Europe, Africa and Asia, under a license from Yakult Honsha Co. Limited,

| — | for undertaking Sanofi-Aventis: pharmaceutical company, which discovers, develops, manufactures, and markets human pharmaceuticals, vaccines, animal health and chemicals products. |
| --- | --- |

—

for undertaking Sanofi-Aventis: pharmaceutical company, which discovers, develops, manufactures, and markets human pharmaceuticals, vaccines, animal health and chemicals products.

| 3. | On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EEC) No 4064/89 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EEC) No 4064/89 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax no. +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3497 — Pfizer/Campto, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel. |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax no. +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3497 — Pfizer/Campto, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel.

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  OJ C 217, 29.7.2000, p. 32; Council Regulation (EEC) No 4064/89 has been replaced by Council Regulation (EC) No 139/2004.

---

| 9.7.2004 | EN | Official Journal of the European Union | C 177/4 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/4

---

Non-opposition to a notified concentration

(Case No COMP/M.3414 — APAX/CAPMAN/SOLID)

(2004/C 177/04)

(Text with EEA relevance)

On 1 July 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EEC) No 4064/89. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3414. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below: |
| --- | --- |

—

in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3414. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below:

CELEX: subscriber information

http://publications.eu.int/general/en/eulaw_en.htm

---

| 9.7.2004 | EN | Official Journal of the European Union | C 177/4 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/4

---

Non-opposition to a notified concentration

(Case No COMP/M.3411 — UGC / NOOS)

(2004/C 177/05)

(Text with EEA relevance)

On 17 May 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EEC) No 4064/89. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3411. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below: |
| --- | --- |

—

in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3411. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below:

CELEX: subscriber information

http://publications.eu.int/general/en/eulaw_en.htm

---

| 9.7.2004 | EN | Official Journal of the European Union | C 177/5 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/5

---

Non-opposition to a notified concentration

(Case No COMP/M.3382 — IBERIA / COBRA INSTALACIONES / SERPISTA JV)

(2004/C 177/06)

(Text with EEA relevance)

On 5 May 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EEC) No 4064/89. The full text of the decision is available only in Spanish and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CEN’ version of the CELEX database, under document number M.3382 - IBERIA / COBRA INSTALACIONES / SERPISTA JV. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below: |
| --- | --- |

—

in electronic form in the ‘CEN’ version of the CELEX database, under document number M.3382 - IBERIA / COBRA INSTALACIONES / SERPISTA JV. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below:

CELEX: subscriber information

http://publications.eu.int/general/en/eulaw_en.htm

---

| 9.7.2004 | EN | Official Journal of the European Union | C 177/5 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/5

---

Non-opposition to a notified concentration

(Case No COMP/M.3460 — CHARTERHOUSE / AUTOBAR)

(2004/C 177/07)

(Text with EEA relevance)

On 17 June 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3460. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below: |
| --- | --- |

—

in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3460. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below:

CELEX: subscriber information

http://publications.eu.int/general/en/eulaw_en.htm

---